91. The Psychedelic Industry with Josh Hardman
About this episode
In this episode, Josh Hardman, the founder of Psychedelic Alpha, explores the multitude of challenges currently being encountered by the psychedelic industry. He engages in discussions regarding the progress of decriminalisation and legalisation initiatives, upcoming clinical trial milestones, and delves into the current state and the potential evolution of the Psychedelic industry.
★ Support this podcast ★
Get every episode summarized
Each time The Drug Science Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Drug Science Podcast
158. The Story of Pharmacology with Prof Rod Flower
The Drug Science Podcast
157. Psychedelics and Christianity with Wendi Rees
The Drug Science Podcast
156. Training Grandmothers to Treat Depression with Dr Dixon Chibanda
The Drug Science Podcast
155. The History of Schizophrenia with Justin Garson
The Drug Science Podcast